Lifeclean International

LifeClean International develops, manufactures and sells desinfection, decontamination and premium cleaning products through a group structure centered on LifeClean and Kempartner Ocean AB. The business serves regulated end markets in Europe and selected international markets, with production in Vadstena and a mix of own-brand sales, private label manufacturing and licensing arrangements.

— Lifeclean International
%
Desinfection products35% Regulated high-level desinfection products used in healthcare and other controlled environments.
PFAS remediation15% Products and solutions for removing PFAS from contaminated surfaces and systems.
Premium cleaning products25% Own-brand environmentally profiled detergents, dish and cleaning products.
Private label manufacturing20% Contract manufacturing of chemical products for partners under their brands.
Licensing and technology access5% Licenses that allow partners to produce and commercialize LifeClean technology in defined geographies.

LifeClean sells to healthcare and other regulated environments where desinfection and sanitation are system-critical...

  • Healthcare providersprimary

    Buy desinfection products for continuous use in medically regulated environments where reliability and documentation matter.

  • Agriculture and poultry operatorssecondary

    Buy hygiene and biosafety solutions for short-cycle production environments.

  • Industrial remediation customerssecondary

    Buy PFAS decontamination products for contaminated equipment, surfaces and systems.

  • Private label partnersprimary

    Buy contract-manufactured chemical products produced at Kempartner Ocean AB's facility.

  • Retail consumers and shopssecondary

    Buy own-brand detergents, dish and cleaning products through stores and webshops.

LifeClean is headquartered in Uddevalla, Sweden, with production activities in Vadstena through Kempartner Ocean AB...

  • •Headquartered in Uddevalla, Sweden
  • •Production site in Vadstena through Kempartner Ocean AB
  • •Europe is a core market because of regulation
  • •Licensing is used to reach markets outside Europe
  • •PFAS opportunities are discussed for North America and Asia

LifeClean's strategy is to build value through focused market selection, disciplined resource allocation and...

01
Partner-based market expansionshort-term

Local partners provide distribution, regulatory know-how and faster implementation.

02
Licensing outside Europemedium-term

Licensing supports geographic scale with limited capital tied up in operations.

03
Regulated end-market focusmedium-term

Healthcare, agriculture and remediation demand documented performance and recurring need.

LifeClean is exposed to regulatory, market and supplier risks because its products operate in tightly controlled...

high

Regulatory compliance risk

Products must meet biocidal, chemical and medical-device related rules in multiple jurisdictions.

Scope
Europe and other active markets
Materiality
high
high

Intellectual property risk

Patent applications may not be granted and competitors may infringe or copy formulations.

Scope
PFAS remediation and desinfection technology
Materiality
high
high

Liquidity and financing risk

The company has relied on external funding to support operations and growth initiatives.

Scope
Corporate level
Materiality
high
medium

Partner execution risk

The model relies on distributors, licensees and local partners to commercialize products.

Scope
International expansion
Materiality
medium
medium

Market adoption risk

New remediation and desinfection solutions can face long qualification cycles and slow uptake.

Scope
Healthcare, agriculture, industrial remediation
Materiality
medium
Revenue recognition
Affects timing of reported sales across product, private label and licensing activities
Intangible asset impairment
Could materially affect earnings if recoverability weakens
Inventory and production accounting
Affects gross profit and working capital
Financing and liquidity disclosures
Affects leverage, liquidity and going-concern analysis

LIFECORE BIOMEDICAL, INC. \DE\

LFCR · Pharmaceutical Preparations

Lifevantage Corp

LFVN · Pharmaceutical Preparations

Life360, Inc.

LIF · Services-Computer Processing & Data Preparation

LifeMD, Inc.

LFMD · Services-Offices & Clinics of Doctors of Medicine

LIPELLA PHARMACEUTICALS INC.

LIPO · Pharmaceutical Preparations

ORIGINCLEAR, INC.

OCLN · Special Industry Machinery, NEC

: 11/08/2026